Recent Advances in miRNA Biomarkers for Diagnosis and Prognosis of Focal Segmental Glomerulosclerosis.

Kidney Dis (Basel) · 2025 · PMC12094685 · PMID 40401151

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Overall, we believe that the advantages of miRNAs as disease biomarkers are highly significant and, to some extent, irreplaceable.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.